Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
New England Journal of Medicine · 27.02.2025 · 392 (9) · 875-891
DOI: 10.1056/nejmoa2411680 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 27.02.2025. Verfasst von Sumit Gupta und 32 weiteren Autor:innen. Beteiligte Einrichtung: Division of Haematology-Oncology, University of Toronto, Toronto. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Antineoplastic Combined Chemotherapy Protocols, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 248-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, St. Baldrick’s Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Haematology-Oncology, University of Toronto, Toronto.
- Faculty of Medicine, University of Toronto, Toronto.
- Seattle Children's Hospital, Seattle.
- Ben Towne Center for Childhood Cancer and Blood Disorders Research and Department of Pediatrics, Fred Hutchinson Cancer Center, University of Washington, Seattle.
- Department of Biostatistics, Colleges of Medicine, Public Health, and Health Professions, University of Florida, Gainesville.
- Division of Pediatric Hematology-Oncology, Texas Children's Cancer Center and Hematology Center, Baylor College of Medicine, Houston.
ORCID-Profile: Sumit Gupta, Karen R Rabin, Lia Gore, Mignon L Loh
Förderung
- NCI NIH HHS
- National Cancer Institute
- St. Baldrick’s Foundation
Zitieren
APA
Gupta, S., Rau, R. E., Kairalla, J. A., Rabin, K. R., Wang, C., Angiolillo, A. L., Alexander, S., Carroll, A. J., Conway, S., Gore, L., Kirsch, I., Kubaney, H. R., Li, A. M., McNeer, J. L., Militano, O., Miller, T. P., Moyer, Y., O'Brien, M. M., Okada, M., …, & Loh, M. L. (2025). Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. New England Journal of Medicine, 392(9), 875-891. https://doi.org/10.1056/nejmoa2411680
Vancouver
Gupta S, Rau RE, Kairalla JA, Rabin KR, Wang C, Angiolillo AL, et al. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. New England Journal of Medicine. 2025;392(9):875-891. doi:10.1056/nejmoa2411680
BibTeX
@article{Gupta2025,
author = {Gupta, Sumit and Rau, Rachel E and Kairalla, John A and Rabin, Karen R and Wang, Cindy and Angiolillo, Anne L and Alexander, Sarah and Carroll, Andrew J and Conway, Susan and Gore, Lia and Kirsch, Ilan and Kubaney, Holly R and Li, Amanda M and McNeer, Jennifer L and Militano, Olga and Miller, Tamara P and Moyer, Yvonne and O'Brien, Maureen M and Okada, Maki and Reshmi, Shalini C and Shago, Mary and Wagner, Elizabeth and Winick, Naomi and Wood, Brent L and Haworth-Wright, Tara and Zaman, Faraz and Zugmaier, Gerhard and Zupanec, Sue and Devidas, Meenakshi and Hunger, Stephen P and Teachey, David T and Raetz, Elizabeth A and Loh, Mignon L},
title = {Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {9},
pages = {875--891},
doi = {10.1056/nejmoa2411680}
}
EUVIMED